INPP4B抑癌基因调控EGFR转运并促进三阴性乳腺癌
该研究构建INPP4B缺陷的三阴性乳腺癌(TNBC)基因工程小鼠模型,发现INPP4B纯合和杂合敲除小鼠肿瘤发生率呈剂量依赖性增加,证实其抑癌作用。机制上INPP4B缺失增加内吞囊泡中PI(3,4)P2水平,延迟EGFR和MET降解并促进受体酪氨酸激酶再循环,延长信号输出。INPP4B缺陷小鼠对PI3K或MEK抑制剂更敏感。
要点
- INPP4B纯合和杂合敲除小鼠肿瘤发生率呈剂量依赖性高于野生型。
- INPP4B缺失延迟EGFR和MET降解,促进RTK再循环,延长PI3K和ERK激活。
- INPP4B缺陷小鼠对PI3K或MEK抑制剂更敏感。
核心结论
- INPP4B在TNBC中发挥抑癌作用,其失活通过调控RTK再循环和信号持续时间促进肿瘤发生。
研究设计与样本
- 研究构建了INPP4B缺陷的TNBC基因工程小鼠模型,比较纯合敲除、杂合敲除与野生型小鼠的肿瘤发生率。
主要发现
- INPP4B纯合和杂合敲除小鼠肿瘤发生率较野生型呈剂量依赖性增加。
- INPP4B敲除小鼠来源的肿瘤富集AKT和MEK基因特征。
- INPP4B缺陷小鼠对PI3K或MEK抑制剂比野生型小鼠更敏感。
- INPP4B缺失增加内吞囊泡中PI(3,4)P2水平,但不增加质膜水平。
- INPP4B缺失延迟EGFR和MET降解,促进RTK再循环,增强生长因子刺激后的信号持续时间和幅度。
临床怎么用
- INPP4B缺陷的TNBC可能对PI3K或MEK抑制剂治疗更敏感,可作为潜在疗效标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Inactivation of the tumor suppressor lipid phosphatase INPP4B is common in triple-negative breast cancer (TNBC). We generated a genetically engineered TNBC mouse model deficient in INPP4B. We found a dose-dependent increase in tumor incidence in INPP4B homozygous and heterozygous knockout mice compared with wild-type (WT), supporting a role for INPP4B as a tumor suppressor in TNBC. Tumors derived from INPP4B knockout mice are enriched for AKT and MEK gene signatures. Consequently, mice with INPP4B deficiency are more sensitive to PI3K or MEK inhibitors compared with WT mice. Mechanistically, we found that INPP4B deficiency increases PI(3,4)P2 levels in endocytic vesicles but not at the plasma membrane. Moreover, INPP4B loss delays degradation of EGFR and MET, while promoting recycling of receptor tyrosine kinases (RTK), thus enhancing the duration and amplitude of signaling output upon growth factor stimulation. Therefore, INPP4B inactivation in TNBC promotes tumorigenesis by modulating RTK recycling and signaling duration. SIGNIFICANCE: Inactivation of the lipid phosphatase INPP4B is frequent in TNBC. Using a genetically engineered mouse model, we show that INPP4B functions as a tumor suppressor in TNBC. INPP4B regulates RTK trafficking and degradation, such that loss of INPP4B prolongs both PI3K and ERK activation.This article is highlighted in the In This Issue feature, p. 1079.
引用
- Liu H, Paddock MN, Wang H, et al. The INPP4B Tumor Suppressor Modulates EGFR Trafficking and Promotes Triple-Negative Breast Cancer. Cancer Discov. 2020. PMID: 32513774. doi:10.1158/2159-8290.CD-19-1262
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。